Howard Bancorp, Inc. (HBMD) News
Filter HBMD News Items
HBMD News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest HBMD News From Around the Web
Below are the latest news stories about Howard Bancorp Inc that investors may wish to consider to help them evaluate HBMD as an investment opportunity.
Why You Shouldn't Bet Against Howard Bancorp (HBMD) StockHoward Bancorp (HBMD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. |
F.N.B.'s bank buy in Baltimore approved by regulatorsF.N.B. Corp. has cleared the main hurdles to its pending acquisition in Maryland. On Tuesday, F.N.B. (NYSE:FNB) said it has received all regulatory clearances for its proposed merger with Baltimore-based Howard Bancorp Inc. Pittsburgh-based F.N.B. announced the $418 million all-stock transaction on July 13, marking its first bank buy in more than four years. The Board of Governors of the Federal Reserve System, the Office of the Comptroller of the Currency and the Maryland Office of the Commissioner of Financial Regulation have provided final clearance for the F.N.B.-Howard (NASDAQ:HBMD) merger as well as the merger of Howard's bank subsidiary, Howard Bank, into F.N.B.’s retail arm, First National Bank of Pennsylvania. |
F.N.B. Corporation Receives Final Regulatory Approval for Howard Bancorp, Inc. MergerF.N.B. Corporation (NYSE: FNB) announced it has received all regulatory clearances for its proposed merger with Howard Bancorp, Inc. (Howard) (NASDAQ: HBMD). |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, HBMD, VNE, IKNX; Shareholders are Encouraged to Contact the FirmHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: |
Lifshitz Law Firm, P.C. Announces Investigation of ADMS, ACBI, FLXN, and HBMDNEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (NasdaqGM: ADMS) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of ADMS to Supernus Pharmaceuticals, Inc. for $8.10 in cash per share of ADMS owned. If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at |
Howard Bancorp (HBMD) Q3 Earnings and Revenues Surpass EstimatesHoward Bancorp (HBMD) delivered earnings and revenue surprises of 3.03% and 0.32%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? |
Howard Bancorp, Inc. Reports Third Quarter 2021 ResultsBALTIMORE, October 20, 2021--Howard Bancorp, Inc. Reports Third Quarter 2021 Results |
Howard Bancorp (HBMD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseHoward Bancorp (HBMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GTS, HBMD, SBKK, VICI; Shareholders are Encouraged to Contact the FirmNEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Triple-S Management Corporation (NYSE: GTS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to GuideWell Mutual Holding Corporation for $36.00 per share in cash. If you are a Triple-S Management shareholder, click here to learn more about your rights and options. Howard Banco |
Howard Bancorp, Inc. Announces Third Quarter 2021 Earnings Release DateBALTIMORE, October 07, 2021--Howard Bancorp, Inc. Announces Third Quarter 2021 Earnings Release Date |